Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422160 · ClinicalTrials.gov registry record
Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 28
- Enrollment target
NCT02422160: Completed study, sponsored by Stanford University.
NCT02422160 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 28 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422160 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 28 participants
- Enrollment target
Study Summary
The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practice on each patient visit to the ophthalmologist. The investigators' goal is to evaluate whether this method will improve the ability to detect AMD earlier and improve visual outcomes in AMD patients by assigning patient risk categories and having patients come back for follow up based on those categories.
Interventions
- OTHER No interventions are planned
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2015-04 |
| Est. Completion | 2021-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422160
The ClinicalTrials.gov registry entry for NCT02422160 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No interventions are planned is the first listed.
NCT02422160 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02422160 about?
NCT02422160 is a clinical study titled "Vision Outcomes Using Quantitative Optical Coherence Tomography Evaluation in Age Related Macular Degeneration". The investigators have developed an image analysis method that can predict the likelihood that a patient with age related macular degeneration (AMD) will progress within 1 year, based on computerized analysis of optical coherence tomography (OCT) images that are routinely acquired in clinical practi...
What is the current status of trial NCT02422160?
This trial is currently completed. The enrollment target is 28 participants. The study started on 2015-04. Estimated completion is 2021-12.
What interventions are being tested in trial NCT02422160?
The interventions under investigation include: No interventions are planned (OTHER).
Who is sponsoring clinical trial NCT02422160?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.